Many congratulations to @pogorely.bsky.social & @pgtimmune.bsky.social and their team, very excited to see this work finally published! Such a fantastic new method for TCR analysis! Looking forward to using it myself :)

I'm deeply honoured & grateful to have been awarded the #CSLCentenaryFellowship at the #AAHMS dinner last week Many thanks to my mentors & colleagues for their support Congratulations to my Fellow winner @rhyswg.bsky.social #MedicalResearch #CSLCentenaryFellowships #WomenInSTEMM @mcri.bsky.social

Big congratulations well deserved winners who did amazing work!! 🥳🥳

Key takeaways from today’s #ESWI2025 plenary: 🇺🇸 Shifting US priorities reshape global research 🇪🇺🇨🇦 EU & Canada face widening funding gaps 👩‍🔬Early-career scientists struggle to find stable paths need support from established scientists 🔄 Collaboration & support are essential

What a great session and fantastic advice from the panel on how to navigate your career. With fantastic questions from our ECR/ECaS audience. Choose/find a path that you are passionate about and a career is rarely a straight line

Great work by @chinweetan.bsky.social , @Len Dalit and @groomlab.bsky.social and her team understanding the signatures behind T folicular helper heterogeneity! ⬇️ #ImmunoSky

📢 Very proud to present @tejas-the-tcell.bsky.social 2nd First Author paper published in @pnas.org where he showed that key #TCR repertoires & gene expression profiles can be found in #influenza CD8 T central memory cell pools across the human lifespan. #AgingResearch doi.org/10.1073/pnas.2501167122

Thanks for the memories! Proud to have our study on central memory CD8+ T cells across the human lifespan published in PNAS today! You can read our paper: go.unimelb.edu.au/rp7p Or our article: go.unimelb.edu.au/jp7p @thedohertyinst.bsky.social‬ @cvandesandt.bsky.social‬ @katherinekedz.bsky.social‬

🚨 #ESWI2025 🚨 Key upcoming deadlines 🐦 Early bird registration ends on 30 June 2025 🚀 Extra call for abstracts in #Molecular #Virology open until 31 July 2025 🚀 Late breaker abstract submission is open until 10 August eswiconference.org/abstract-sub...

📢Very proud to present @jetvddijssel.bsky.social her final paper for her PhD in @eurjimmunol.bsky.social where we used the latest #Nanovial technology to activate CD8 T cells and link their TCRs to IFNy levels without the need to fix them! doi.org/10.1002/eji.... @thedohertyinst.bsky.social @Sanquin

🗓️ Only 3 weeks to go! 📍#ESWI2025 📆 20–23 October 2025 | Valencia, Spain 📝 Abstract submission deadline: 16 May 2025 🚨 Don’t miss your chance to contribute to the largest European #scientific conference on #Influenza & #AcuteRespiratoryVirus diseases eswiconference.org/abstract-sub...

Your immune system gradually loses it top team players when we get older 👱➡️👵 Our study in @ebiomedicine.bsky.social investigates how long good immune cells stay around – a 🧵⬇️ go.unimelb.edu.au/4sep @katherinekedz.bsky.social @thedohertyinst.bsky.social #Influenza #AgingResearch #Immunity #TCR

Do age & CMV affect the generation of T cell responses against novel pathogens? 🧑‍🔬 Our @eurjimmunol.bsky.social study shows broad & robust memory #SARS-CoV-2 specific T cell response regardless of age or CMV #Ageingresearch.🧵⬇️ go.unimelb.edu.au/w76p @jetvddijssel.bsky.social @Sanquin @TheDohertyInst

Interested to learn about potential off-target effects from the #BCGvaccine on the #SARSCoV2 vaccine response? Check out the latest work by @nicolemessina.bsky.social and her team @mcri.bsky.social with whom we collaborated! ⬇️

🌟 #ESWI 🏆 Awards are open for #EarlyCareerScientists! 🌟 ✨ Claude Hannoun Prize for Best Body of Work 📅 Deadline: 28 February 2025 Apply now 👉 www.eswiconference.org/eswi-awards/... @cvandesandt.bsky.social was 2023 winner! 💬 eswi.org/site/young-s... Will you be next?

📢 Great opportunity for #EarlyCareerResearchers working on respiratory virus infections like #Influenza #Covid_19 #RSV or #Vaccine innovations & those from under-represented communities ⬇️🧑‍🔬 Put in your application before Feb 28th! More information: eswiconference.org/eswi-awards #ECR #Awards #ESWI

💭 What's at the top of @cvandesandt.bsky.social wish list for #vaccineplatformtechnology in the short-term? To include high-risk groups in clinical trials ensuring vaccines are as effective as for healthy individuals. 🎧 Tune in to #ESWIAirborne on #FluVaccines shorturl.at/jvVt2 #ESWIEducationHub

🎯Prestigious Academic Journals @bsky.app Active: Science: @science.org Nature: @natureportfolio.bsky.social Still Not Active: Cell: @cellpress.bsky.social Active Medical Journals: NEJM: @nejm.org JAMA: @jama.com Lancet: @thelancet.bsky.social BMJ: @bmj.com

Check out our new preprint where we investigated the attachment and replication of a clade 2.3.4.4b HPAIV H5N1 isolate (Caspian Gull origin) in human respiratory tissues. www.biorxiv.org/content/10.1...

BLUESKY MEGA-THREAD Altmetric is thrilled and also LITERALLY RELIEVED to officially announce: We are now tracking research attention as it happens on Bluesky! We have been picking up posts on the site since late Oct. Our team is on Bluesky all day answering questions. Let's get into it!

How does antiviral #immunity against #influenza evolve across human lifespan? 👶➡️👧➡️👱➡️👵 Our study in Nature Immunology investigates the difference in CD8 T cell response across human lifespan - a🧵⬇️ go.unimelb.edu.au/627s Katherine Kedzierska, Fabio Luciani, The Doherty Institute